Scholarlink

Introduction <p>Interstitial lung disease (ILD) is frequently complicated by pulmonary hypertension (PH) resulting in reduced functional capacity, diminished quality of life, and increased mortality. However, standardized screening for PH in ILD is lacking, causing delays in diagnosis and treatment. PHINDER (NCT05776225) is a prospective multicenter study that aims to identify parameters for the detection of PH in ILD.</p> Methods <p>Data were collected prospectively in patients with ILD from predefined routine testing, including clinical, physiological, and imaging assessments. Precapillary PH was defined as mean pulmonary arterial pressure &gt; 20&#xa0;mmHg, pulmonary artery wedge pressure ≤ 15&#xa0;mmHg, and pulmonary vascular resistance (PVR) &gt; 2&#xa0;Wood units (WU). Investigators estimated probability of precapillary PH based on noninvasive evaluations before confirmation by right heart catheterization (RHC).</p> Results <p>Preliminary results included 190 participants; 105 (55%) had precapillary PH and 26 (14%) had severe PH (PVR &gt; 5&#xa0;WU). Notable parameters associated with precapillary PH included supplemental oxygen use (OR 3.6, <i>p</i> = 0.004), diffusing capacity of the lung for carbon monoxide ([DLCO] OR 0.9, <i>p</i> = 0.005), forced vital capacity % to DLCO % ratio (OR 1.1, <i>p</i> = 0.008), tricuspid annular plane systolic excursion to right ventricular systolic pressure ratio (OR 0.8, <i>p</i> = 0.020), tricuspid regurgitant velocity (OR 4.4, <i>p</i> = 0.006), pulmonary artery (PA) enlargement (OR 10.6, <i>p</i> &lt; 0.001), PA/aorta diameter ratio (OR 1.7, <i>p</i> = 0.004), and right to left ventricle diameter ratio (OR 1.5, <i>p</i> = 0.021). There was a trend toward higher likelihood of PH with higher clinician suspicion of PH before RHC, but gestalt-based assessment showed limited accuracy relative to hemodynamic confirmation (positive predictive value, 59%; negative predictive value, 68%; accuracy, 60%).</p> Conclusions <p>Preliminary findings support the composite use of pulmonary function testing, lung imaging, and echocardiography to improve early detection of precapillary PH in ILD and guide structured screening strategies. The final data set from PHINDER will provide guidance on thresholds for continuous variables with application in diagnosing PH in ILD, facilitating the development of a validated evidence-based screening tool to aid the detection of PH in ILD.</p> Trail Registration <p>NCT05776225.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月10日

查看全文
  • David Zisman,
  • Sandeep Sahay,
  • Debabrata Bandyopadhyay,
  • Amro Al-Astal,
  • Meredith Broderick,
  • Danielle Caudell Stamper,
  • Hunter Champion,
  • Maral DerSarkissian,
  • Matthew Hunsucker,
  • Dasom Lee,
  • Kevin Maher,
  • Andrew Nelsen,
  • Raj Parikh,
  • Franck Rahaghi,
  • Abhijit Raval,
  • Claire M. Thrasher,
  • Tejaswini Kulkarni,
  • Oksana A. Shlobin,
  • David G. Kiely,
  • Steven Nathan,
  • Mary Beth Scholand

摘要

Introduction

Interstitial lung disease (ILD) is frequently complicated by pulmonary hypertension (PH) resulting in reduced functional capacity, diminished quality of life, and increased mortality. However, standardized screening for PH in ILD is lacking, causing delays in diagnosis and treatment. PHINDER (NCT05776225) is a prospective multicenter study that aims to identify parameters for the detection of PH in ILD.

Methods

Data were collected prospectively in patients with ILD from predefined routine testing, including clinical, physiological, and imaging assessments. Precapillary PH was defined as mean pulmonary arterial pressure > 20 mmHg, pulmonary artery wedge pressure ≤ 15 mmHg, and pulmonary vascular resistance (PVR) > 2 Wood units (WU). Investigators estimated probability of precapillary PH based on noninvasive evaluations before confirmation by right heart catheterization (RHC).

Results

Preliminary results included 190 participants; 105 (55%) had precapillary PH and 26 (14%) had severe PH (PVR > 5 WU). Notable parameters associated with precapillary PH included supplemental oxygen use (OR 3.6, p = 0.004), diffusing capacity of the lung for carbon monoxide ([DLCO] OR 0.9, p = 0.005), forced vital capacity % to DLCO % ratio (OR 1.1, p = 0.008), tricuspid annular plane systolic excursion to right ventricular systolic pressure ratio (OR 0.8, p = 0.020), tricuspid regurgitant velocity (OR 4.4, p = 0.006), pulmonary artery (PA) enlargement (OR 10.6, p < 0.001), PA/aorta diameter ratio (OR 1.7, p = 0.004), and right to left ventricle diameter ratio (OR 1.5, p = 0.021). There was a trend toward higher likelihood of PH with higher clinician suspicion of PH before RHC, but gestalt-based assessment showed limited accuracy relative to hemodynamic confirmation (positive predictive value, 59%; negative predictive value, 68%; accuracy, 60%).

Conclusions

Preliminary findings support the composite use of pulmonary function testing, lung imaging, and echocardiography to improve early detection of precapillary PH in ILD and guide structured screening strategies. The final data set from PHINDER will provide guidance on thresholds for continuous variables with application in diagnosing PH in ILD, facilitating the development of a validated evidence-based screening tool to aid the detection of PH in ILD.

Trail Registration

NCT05776225.